The Joint Steering Committee. Promptly after the Effective Date, the Parties shall establish a Joint Steering Committee (the "JSC") as set forth in this Section 2.5. The JSC will exist throughout the term of this Agreement.
The Joint Steering Committee. Promptly and in any event within ninety (90) days after the Effective Date, the Parties shall establish a committee (the “Joint Steering Committee” or “JSC”) as more fully described in this Section 2.3. The JSC shall have review and oversight responsibilities for all research and Development activities performed hereunder during the Research Term and with respect to each Early Development Program prior to exercise of a Product Option by GSK, and shall serve as a vehicle to facilitate the conduct of information between the Parties with respect to any commercialization activities and the Product Candidate Commercialization Program, in each case as more specifically provided herein. Each Party agrees to keep the JSC informed of its progress and activities within the Research Program, each Early Development Program, and each Product Candidate Commercialization Program, respectively.
The Joint Steering Committee. Promptly and in any event within ninety (90) days after the Effective Date, the Parties shall establish a committee (the “Joint Steering Committee” or “JSC”) as more fully described in Sections 2.3.1 through 2.3.8 of this Section 2.3. The JSC shall have review and oversight responsibilities for all research and Development activities performed hereunder during the Research Term and with respect to each Early Development Program prior to exercise of a Product Option by GSK, and shall serve as a vehicle to facilitate the conduct of information between the Parties with respect to any commercialization activities and the Product Candidate Commercialization Program, in each case as more specifically provided herein. Each Party agrees to keep the JSC informed of its progress and activities within the Research Program, each Early Development Program, and each Product Candidate Commercialization Program, respectively. At its sole discretion, ChemoCentryx may terminate its participation in the JSC upon the earlier of (a) the date on which GSK exercises its Product Option for the sixth (6th) Option Compound, (b) the date on which the JSC agrees to terminate the Research Program and all Early Development Programs then in progress without either the JSC or GSK nominating a substitute Backup Compound for the lead Development Candidate against Collaboration Targets being developed under such Early Development Programs; or (c) ten (10) years from the Effective Date. In the event that ChemoCentryx elects to terminate its participation on the JSC pursuant to subsection (c) herein, the Parties understand and agree that (i) if at such time there is on-going an Early Development Program as of such election date, such Early Development Program shall remain in effect and continue (unless otherwise terminated in accordance with Section 3.2.3) and remain subject to the terms and conditions of this Agreement; and (ii) GSK shall assume sole decision-making authority with respect to all decisions otherwise delegated to the JSC under Section 2.3.7 with respect to any such continuing Early Development Program.
The Joint Steering Committee. 2.2.1 shall hold meetings in person as frequently as the members of the JSC may agree shall be necessary and otherwise by teleconference or a video-conference but in any event no less frequently than four times a Year until the end of December 2007, with the first such meeting occurring not later than 31 March in each Year and the third such meeting not later than 31 October in such Year. Thereafter, the Parties shall discuss and agree the frequency with which JSC meetings shall be held. Dates of meetings shall be agreed by the Parties not less than thirty (30) days beforehand; responsibility for arranging the meetings, including, at least, providing notice and an agenda, shall be the responsibility of the Chairperson for that meeting; the first meeting will take place as soon as practicable after the Effective Date, but in no event later than twenty (20) Business Days after the Effective Date and will be organised by Licensee. At such first meeting the JSC shall agree and establish a timetable for the transfer of the Licensor Know How;
The Joint Steering Committee. 2.1 Within [***] days after the Closing Date, the Parties shall establish a joint steering committee, or JSC, which shall have overall responsibility for overseeing the collaboration between the Parties.
The Joint Steering Committee. On or within thirty (30) days after the Effective Date, the Parties shall establish the Joint Steering Committee (“JSC”) to oversee and manage the relationship between the Parties. In particular, the JSC shall be responsible for: ***
The Joint Steering Committee. As soon as practicable after the Effective Date, the BCGT and Xxxxx will establish a Joint Steering Committee (the “JSC”). The JSC will have review and oversight responsibilities for all research, discovery and development activities performed under this Agreement during the Research Term, as more specifically provided herein; provided, however, that the JSC will have no authority to amend this Agreement. BCGT and Xxxxx agree to keep the JSC reasonably informed of its progress and activities under the Research Program during the Research Term.
The Joint Steering Committee. Promptly and in any event within ninety (90) days after the Effective Date, the Parties shall establish and convene a committee (the “Joint Steering Committee” or “JSC”), which shall (i) have review and oversight responsibilities with respect to each Research Program and Early Development Program and (ii) serve as a vehicle to facilitate the transfer of information between the Parties with respect to any commercialization activities and the Product Candidate Commercialization Program, in each case as more specifically provided herein. Each Party agrees to keep the JSC informed of its progress and activities within each Research Program, Early Development Program, and Product Candidate Commercialization Program.
The Joint Steering Committee. The Joint Steering Committee (JSC) oversees the joint selection of projects, but is not actually involved in the selection process. The Joint Evaluation Committee operates in full autonomy. The JSC cannot change the Evaluation Committee's scores or recommendations and cannot alter the evaluation grids. The JSC formally ratifies the Evaluation Report and the award proposals and pass them on (together with recommendations, as appropriate) to the IA/CA for endorsement and onward transmission to EC Delegations for final approval.
The Joint Steering Committee. The parties will establish a Joint Steering Committee (the “Joint Steering Committee”) to coordinate the parties’ activities with respect to the Manufacturing and supply of Product under this Agreement and to providing support to the Relationship Managers (as defined below). The Joint Steering Committee will be composed of [***] representatives (or a greater number as determined by the Joint Steering Committee) appointed by each of Client and Patheon, including the parties’ respective Relationship Manager (as defined below) and representing the functional areas of quality assurance, manufacturing/product supply or such other function areas as the Joint Steering Committee will determine, with at least one representative of each party having decision making authority for that party. Either party may replace any of its representatives on the Joint Steering Committee at any time upon prior written notice to the other party. The Joint Steering Committee will meet at least [***] or as otherwise agreed by the Joint Steering Committee, which meetings will occur by teleconference, videoconference or in person. The Joint Steering Committee will keep minutes of its meetings. The Joint Steering Committee will make decisions by consensus and the members of the Joint Steering Committee will act in good faith. A member of the Joint Steering Committee may invite other individuals to meetings of the Joint Steering Committee as the need arises and these invitees will not be unreasonably be objected to by the other members of the Joint Steering Committee.
